The ASUNCTIS trial evaluated asunercept’s safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients
- Post author:
- Post published:November 18, 2024
- Post category:uncategorized